Virologic Responses and Safety of the current NS3/4A Protease Inhibitors (Telaprevir and Boceprevir) in HCV Treatment-Experienced patientsOmar Mousa,Ly-Elaine Pham,Chukwuma I. Egwim,Scott A. Zela,Victor Ankoma-SeyHEPATOLOGY(2012)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要